ORLANDO, FL USA (UroToday.com) - Presented by Matthew Cooperberg, Stephen J. Freedland, Thorsten Schlomm, Julia E. Reid, Steven Stone, and Michael K. Brawer at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Myriad Genetic Laboratories, Inc., Salt Lake City, UT; University of California, San Francisco, San Francisco, CA; Duke University Medical Center and Durham VA Medical Center, Durham, NC; University Medical Center Hamburg-Eppendorf, Hamburg,Germany; Myriad Genetics, Inc., Salt Lake City, UT
Click HERE to listen to an interview with Matthew R. Cooperberg, MD, MPH, one of the authors of this study